Enavate Sciences GP, LLC

Holdings History for Immunome Inc. - Common Stock, $0.0001 par value per share (IMNM)

Symbol: IMNM on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share
Latest Disclosed Shares Owned: 4,768,583 shares
Security Ownership %: 4.3%

Shares, Excluding Options vs Price

Value, Excluding Options

Enavate Sciences GP, LLC ownership in Immunome Inc. Common Stock, $0.0001 par value per share (IMNM)

22 Dec 2025 - Enavate Sciences GP, LLC has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,768,583 shares of Immunome Inc. Common Stock, $0.0001 par value per share (IMNM). This represents 4.3% ownership of the company. This is the first filing by Enavate Sciences GP, LLC disclosing ownership of Immunome Inc. Common Stock, $0.0001 par value per share (IMNM).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Enavate Sciences GP, LLC	4.3%		$73,483,864	4,768,583			$15.41	13D/A	18 Dec 2025	22 Dec 2025, 21:22

Holdings date	Weight	Change	Value $	Shares	Change	Price	All Holders
31 Dec 2025	20%	0%	$102,429,163	4,768,583	0	$21.48	Q4 2025
30 Sep 2025	17%	0%	$55,840,107	4,768,583	0	$11.71	Q3 2025
30 Jun 2025	25%	0%	$44,347,822	4,768,583	0	$9.30	Q2 2025
31 Mar 2025	24%	+6.5%	$32,092,564	4,768,583	+1,290,322	$6.73	Q1 2025
31 Dec 2024	27%	0%	$36,939,132	3,478,261	0	$10.62	Q4 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.